Medpace Holdings Inc
Closed
SectorHealthcare
466.48 1.86
Overview
Share price change
24h
Min
453.61
Max
470.6
Income | -11M 124M |
|---|---|
Sales | -1.8M 707M |
P/E Sector Avg | 28.817 49.052 |
EPS | 4.28 |
Profit margin | 17.53 |
Employees | 6,300 |
EBITDA | -16M 148M |
Recommendations | Buy |
|---|---|
12 Months Forecast | -2.27% downside |
Next Earnings | 20 Jul 2026 |
|---|
Market Cap | -2B 13B |
|---|---|
Previous open | 464.62 |
Previous close | 466.48 |
Medpace Holdings Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Medpace Holdings Inc Forecast
Price Target
By TipRanks
-2.27% downside
12 Months Forecast
Average 447.5 USD -2.27%
High 495 USD
Low 393 USD
Based on 8 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
